Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastases

  • A.K.E. Elfrink*
  • , E.W. van Zwet
  • , R.J. Swijnenburg
  • , M. den Dulk
  • , P.B. van den Boezem
  • , J.S.D. Mieog
  • , W.W. te Riele
  • , G.A. Patijn
  • , W.K.G. Leclercq
  • , D.J. Lips
  • , A.M. Rijken
  • , C. Verhoef
  • , K.F.D. Kuhlmann
  • , C.I. Buis
  • , K. Bosscha
  • , E.J.T. Belt
  • , M. Vermaas
  • , N.T. van Heek
  • , S.J. Oosterling
  • , H. Torrenga
  • H.H. Eker, E.C.J. Consten, H.A. Marsman, M.W.J.M. Wouters, N.F.M. Kok, D.J. Grunhagen, J.M. Klaase, Dutch Hepato Biliary Audit Group
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Differences in patient demographics and disease burden can influence comparison of hospital performances. This study aimed to provide a case-mix model to compare short-term postoperative outcomes for patients undergoing liver resection for colorectal liver metastases (CRLM).

Methods: This retrospective, population-based study included all patients who underwent liver resection for CRLM between 2014 and 2018 in the Netherlands. Variation in case-mix variables between hospitals and influence on postoperative outcomes was assessed using multivariable logistic regression. Primary outcomes were 30-day major morbidity and 30-day mortality. Validation of results was performed on the data from 2019.

Results: In total, 4639 patients were included in 28 hospitals. Major morbidity was 6.2% and mortality was 1.4%. Uncorrected major morbidity ranged from 3.3% to 13.7% and mortality ranged from 0.0% to 5.0%. between hospitals. Significant differences between hospitals were observed for age higher than 80 (0.0%-17.1%, p < 0.001), ASA 3 or higher (3.3%-36.3%, p < 0.001), histopathological parenchymal liver disease (0.0%-47.1%, p < 0.001), history of liver resection (8.1%-36.3%, p < 0.001), major liver resection (6.7%-38.0%, p < 0.001) and synchronous metastases (35.5%-62.1%, p < 0.001). Expected 30-day major morbidity between hospitals ranged from 6.4% to 11.9% and expected 30-day mortality ranged from 0.6% to 2.9%. After case-mix correction no significant outliers concerning major morbidity and mortality remained. Validation on patients who underwent liver resection for CRLM in 2019 affirmed these outcomes.

Conclusion: Case-mix adjustment is a prerequisite to allow for institutional comparison of short-term postoperative outcomes after liver resection for CRLM. (C) 2020 University Medical Center Groningen. Published by Elsevier Ltd.

Original languageEnglish
Pages (from-to)649-659
Number of pages11
JournalEuropean Journal of Surgical Oncology
Volume47
Issue number3
DOIs
Publication statusPublished - 1 Mar 2021

Fingerprint

Dive into the research topics of 'Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastases'. Together they form a unique fingerprint.

Cite this